glutathione mutations in sclc patients Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes Differential KEAP1/NRF2 mediated signaling widens
Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications Oncology Letters The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat? Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small cell lung cancer patients Annals of Oncology Frontiers Molecular subtypes based on ferroptosis related genes and tumor microenvironment infiltration characterization in small cell lung cancer
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



